Description: Curaleaf Holdings, Inc. operates as an integrated medical and wellness cannabis operator in the United States. It cultivates, processes, markets, and/or dispenses a range of cannabis products in various operating markets, including flower, pre-rolls and flower pods, dry-herb vaporizer cartridges, concentrates for vaporizing, concentrates for dabbing, tinctures, lozenges, capsules, and edibles. The company also provides non-cannabis services to licensed cannabis operators in the areas of cultivation, extraction and production, and retail operations. As of January 9, 2019, it operated 39 dispensaries, 12 cultivation sites, and 10 processing sites in 12 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.
Home Page: www.curaleaf.com
301 Edgewater Place
Wakefield,
MA
01880
United States
Phone:
781 451 0159
Officers
Name | Title |
---|---|
Mr. Boris Alexis Jordan | Exec. Chairman |
Mr. Joseph F. Lusardi | Exec. Vice-Chairman |
Mr. Joseph Daniel Bayern | Exec. Officer & Exec. of New Markets |
Mr. Matthew S. Darin | Chief Exec. Officer |
Mr. Edward Kremer | Chief Financial Officer |
Mr. Joe Holland | Exec. VP of Operations |
Mr. Camilo Russi Lyon | Chief Investment Officer |
Mr. Jakob Feinstein | Mang. of Investor Relations |
Mr. Peter Clateman J.D. | Chief Legal Officer |
Mr. James S. Shorris | Chief Compliance Officer |
Exchange: OTCQX
Country: US
Currency: US Dollar ($)
Forward PE: | 39.0625 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 2.3589 |
Price-to-Sales TTM: | 2.5587 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 5600 |